Abstract
This article offers a preliminary examination of the intersection of managed care, HIV prevention, and economic considerations. After introducing a basic framework for evaluating the cost-effectiveness of HIV prevention interventions, it reviews the cost-effectiveness literature. The article also examines how the concerns of managed care organizations impact the cost-effectiveness of HIV prevention efforts, including counseling and HIV antibody testing, small group cognitive-behavioral interventions, and community-level interventions. The article closes with a discussion of non-financial incentives for promoting HIV prevention within a managed care framework.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
